⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of VIDAL France and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
VIDAL France
↗Issy-les-Moulineaux, France
VIDAL France is a leading European provider of clinical information systems and drug databases, widely recognized as a gold standard for pharmacological data. The company provides healthcare professionals with comprehensive drug information, therapeutic decision support, and prescription safety solutions, which are integrated into over 400 medical software applications and used by more than 95% of hospitals in France.
Since 2016, VIDAL Group has been part of the M3 group, a global leader in digital health headquartered in Japan. VIDAL's solutions are designed to improve medical practice and patient safety by providing up-to-date, structured medical data, including information on medications, medical devices, and health products, to clinicians, pharmacists, and other healthcare stakeholders across Europe, Latin America, and the Middle East.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:-
Industry:Digital Health
Sub-Industry:Clinical Decision Support / Health Informatics
SIZE & FINANCIALS
Employees:201-500
Founded:1914
Ownership:subsidiary
Status:operating
FUNDING
Investors:PariSanté Campus
STOCK
Exchange:Tokyo Stock Exchange
Ticker:2413.T
0
CORPORATE STRUCTURE
Parent Company:M3 Group
Acquired By:M3 Group (2016-01-01)
Key Partnerships:Heidi Health (Heidi Evidence), Various medical software vendors (400+ integrations)
COMPETITION
Position:Leader
Competitors:Elsevier (ClinicalKey), Wolters Kluwer (UpToDate), Thieme
LEADERSHIP
Key Executives:
Vincent Bouvier - CEO
Aude Loisy - Directrice médico-stratégique
LINKS
Website:vidal.fr
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with VIDAL France. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.